Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.11.70574523560721.2816
Domestic EquitiesDr. Reddy's Laboratories Ltd.9.47474633059583.8118
Domestic EquitiesDivi's Laboratories Ltd.9.2336927926568.9578
Domestic EquitiesCipla Ltd.7.39432866624455.6212
Domestic EquitiesAurobindo Pharma Ltd.6.52713912690402.1854
Domestic EquitiesLupin Ltd.5.44211769639335.3289
Domestic EquitiesAlkem Laboratories Ltd.4.0037465164246.6997
Domestic EquitiesMankind Pharma Ltd.3.5015873005215.7545
Domestic EquitiesBiocon Ltd.3.21125680217197.8704
Domestic EquitiesGland Pharma Ltd.2.8771947263177.2803
Domestic EquitiesZydus Lifesciences Ltd.2.80411761233172.7858
Domestic EquitiesSyngene International Ltd.2.17592142146134.0769
Domestic EquitiesMedi Assist Healthcare Services Ltd1.77702164815109.4963
Domestic EquitiesAlembic Pharmaceuticals Ltd.1.63371074403100.6662
Domestic EquitiesMetropolis Healthcare Ltd.1.569444187296.7037
Domestic EquitiesThyrocare Technologies Ltd.1.534974747494.5779
Domestic EquitiesPfizer Ltd.1.514318097093.3081
Domestic EquitiesAnthem Biosciences Ltd1.3975105263686.1109
Domestic EquitiesWindlas Biotech Ltd.1.389785765185.6279
Domestic EquitiesSagility India Ltd1.35661905464683.5927
Domestic EquitiesShilpa Medicare Ltd.1.322896314981.5065
Domestic EquitiesMedplus Health Services Ltd1.280493707478.8969
Domestic EquitiesGlenmark Pharmaceuticals Ltd.1.182837882272.8816
Domestic EquitiesAarti Drugs Ltd.1.1756154269072.4370
Domestic EquitiesFine Organic Industries Ltd.1.144515024370.5241
Domestic EquitiesJ.B.Chemicals & Pharmaceuticals Ltd.1.119340000068.9720
Domestic EquitiesStar Health & Allied Insurance1.1019151943767.8960
Domestic EquitiesEmcure Pharmaceuticals Ltd.1.007944570162.1040
Domestic EquitiesFDC Ltd.0.8897119768954.8242
Domestic EquitiesSanofi Consumer Healthcare India Ltd0.889310567654.7972
Domestic EquitiesProcter & Gamble Health Ltd.0.80657801249.6936
Domestic EquitiesAstrazeneca Pharma India Ltd.0.75555502146.5505
Domestic EquitiesYatharth Hospital & Trauma Care Services Pvt Ltd0.746466174645.9947
Domestic EquitiesSenores Pharmaceuticals Ltd0.717864088344.2305
Domestic EquitiesSun Pharma Advanced Research Co. Ltd0.6345279087239.0973
Domestic EquitiesAdvanced Enzyme Technologies Ltd.0.292952176818.0506
Domestic EquitiesHikal Ltd.0.289770000917.8502
Total 95.8817 5908.0449
Cash & Cash Equivalents and Net AssetsTREPS3.6264 223.4527
Cash & Cash Equivalents and Net AssetsNet Current Assets0.3555 21.9067
Cash & Cash Equivalents and Net AssetsCash Margin - Derivatives0.1364 8.4052
Total 4.1183 253.7646
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.